title: CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
abstract: BACKGROUND
  The association between spondyloarthropathy and Crohn's disease is well known. A risk for evolution to Crohn's disease has already been shown in the subgroup of patients with spondyloarthropathy associated with chronic gut inflammation.
  
  
  OBJECTIVE
  To investigate whether the reported polymorphisms in the CARD15 gene, a susceptibility gene for Crohn's disease, are associated with the presence of preclinical intestinal inflammation observed in spondyloarthropathies.
  
  
  METHODS
  104 patients with spondyloarthropathies were studied. All underwent ileocolonoscopy with biopsies between 1983 and 2004. The prevalence of three single nucleotide polymorphisms in the CARD15 gene (R702W, G908R, and 1007fs) was assessed using restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR); the patients were compared with an ethnically matched Crohn's disease population and a control population.
  
  
  RESULTS
  The carrier frequency of R702W, G908R, or 1007fs variants in the spondyloarthropathy populations (20%) was similar to the control population (17%), but increased to 38% in the spondyloarthropathy subgroup with chronic gut inflammation. This frequency was significantly higher than in the other spondyloarthropathy subgroups (p = 0.001) or the control group (p = 0.006), but not different from the Crohn's disease group (49%) (NS). This indicates that CARD15 polymorphisms are associated with a higher risk for development of chronic gut inflammation.
  
  
  CONCLUSIONS
  CARD15 gene polymorphisms clearly identify a subgroup of patients with spondyloarthropathies associated with chronic intestinal inflammation.
authors.affiliation: Department of Gastroenterology, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Laukens
authors.forename: H
authors.initials: H
authors.lastname: Peeters
authors.forename: D
authors.initials: D
authors.lastname: Marichal
authors.forename: B
authors.initials: B
authors.lastname: Vander Cruyssen
authors.forename: H
authors.initials: H
authors.lastname: Mielants
authors.forename: D
authors.initials: D
authors.lastname: Elewaut
authors.forename: P
authors.initials: P
authors.lastname: Demetter
authors.forename: C
authors.initials: C
authors.lastname: Cuvelier
authors.forename: M
authors.initials: M
authors.lastname: Van Den Berghe
authors.forename: P
authors.initials: P
authors.lastname: Rottiers
authors.forename: E M
authors.initials: EM
authors.lastname: Veys
authors.forename: E
authors.initials: E
authors.lastname: Remaut
authors.forename: L
authors.initials: L
authors.lastname: Steidler
authors.forename: F
authors.initials: F
authors.lastname: De Keyser
authors.forename: M
authors.initials: M
authors.lastname: De Vos
mesh_terms: D000293:Adolescent; D000328:Adult; D003424:Crohn Disease / Q000150:complications / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D015796:HLA-B27 Antigen / Q000032:analysis; D006579:Heterozygote; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D053473:Nod2 Signaling Adaptor Protein; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide; D025242:Spondylarthropathies / Q000150:complications / Q000235:genetics*
chemical_list: D015796:HLA-B27 Antigen; D047908:Intracellular Signaling Peptides and Proteins; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein